Sithandiwe E. Mazibuko-Mbeje

2.9k total citations · 2 hit papers
73 papers, 2.0k citations indexed

About

Sithandiwe E. Mazibuko-Mbeje is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Sithandiwe E. Mazibuko-Mbeje has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 26 papers in Physiology and 14 papers in Epidemiology. Recurrent topics in Sithandiwe E. Mazibuko-Mbeje's work include Adipose Tissue and Metabolism (21 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Natural Antidiabetic Agents Studies (9 papers). Sithandiwe E. Mazibuko-Mbeje is often cited by papers focused on Adipose Tissue and Metabolism (21 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Natural Antidiabetic Agents Studies (9 papers). Sithandiwe E. Mazibuko-Mbeje collaborates with scholars based in South Africa, Italy and Namibia. Sithandiwe E. Mazibuko-Mbeje's co-authors include Phiwayinkosi V. Dludla, Bongani B. Nkambule, Khanyisani Ziqubu, Luca Tiano, Johan Louw, Tawanda M. Nyambuya, Sinenhlanhla X. H. Mthembu, Sonia Silvestri, Patrick Orlando and Christo J. F. Muller and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Sithandiwe E. Mazibuko-Mbeje

69 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress

2023 128 citations Phiwayinkosi V. Dludla, Sihle E. Mabhida et al. profile →
Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis of scientific literature

2022 128 citations Ndivhuwo Muvhulawa, Phiwayinkosi V. Dludla et al. Pharmacological Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sithandiwe E. Mazibuko-Mbeje South Africa	25	643	486	397	333	236	73	2.0k
Bongani B. Nkambule South Africa	27	641 1.0×	473 1.0×	438 1.1×	331 1.0×	202 0.9×	122	2.3k
Cristina Carresi Italy	29	892 1.4×	442 0.9×	336 0.8×	241 0.7×	245 1.0×	95	2.5k
Micaela Gliozzi Italy	33	1.1k 1.7×	620 1.3×	318 0.8×	280 0.8×	271 1.1×	108	3.1k
Gerard Aragonès Spain	33	613 1.0×	447 0.9×	469 1.2×	293 0.9×	512 2.2×	105	2.7k
Patchareewan Pannangpetch Thailand	26	635 1.0×	371 0.8×	198 0.5×	405 1.2×	325 1.4×	56	2.0k
Ehsan Ghaedi Iran	27	360 0.6×	528 1.1×	254 0.6×	327 1.0×	202 0.9×	92	1.9k
Hanan S. El‐Abhar Egypt	31	901 1.4×	380 0.8×	243 0.6×	329 1.0×	116 0.5×	104	2.8k
Saverio Nucera Italy	26	676 1.1×	332 0.7×	213 0.5×	197 0.6×	214 0.9×	75	1.9k
Chian‐Jiun Liou Taiwan	33	1.1k 1.6×	468 1.0×	367 0.9×	241 0.7×	220 0.9×	74	2.4k
Youngshim Choi South Korea	24	570 0.9×	529 1.1×	606 1.5×	276 0.8×	135 0.6×	46	1.9k

Countries citing papers authored by Sithandiwe E. Mazibuko-Mbeje

Since Specialization

Citations

This map shows the geographic impact of Sithandiwe E. Mazibuko-Mbeje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sithandiwe E. Mazibuko-Mbeje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sithandiwe E. Mazibuko-Mbeje more than expected).

Fields of papers citing papers by Sithandiwe E. Mazibuko-Mbeje

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sithandiwe E. Mazibuko-Mbeje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sithandiwe E. Mazibuko-Mbeje. The network helps show where Sithandiwe E. Mazibuko-Mbeje may publish in the future.

Co-authorship network of co-authors of Sithandiwe E. Mazibuko-Mbeje

This figure shows the co-authorship network connecting the top 25 collaborators of Sithandiwe E. Mazibuko-Mbeje. A scholar is included among the top collaborators of Sithandiwe E. Mazibuko-Mbeje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sithandiwe E. Mazibuko-Mbeje. Sithandiwe E. Mazibuko-Mbeje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mazibuko-Mbeje, Sithandiwe E., et al.. (2025). The miR-200 family in type 2 diabetes: therapeutic and biomarker perspectives. Journal of Diabetes and its Complications. 40(1). 109211–109211.

Mthembu, Sinenhlanhla X. H., Sithandiwe E. Mazibuko-Mbeje, Sonia Silvestri, et al.. (2025). Prolonged exposure to simvastatin affects coenzyme Q9/10 status leading to impaired mitochondrial respiratory capacity and reduced viability of cultured cardiac cells. Toxicology in Vitro. 106. 106052–106052.

Ziqubu, Khanyisani, et al.. (2024). Aflatoxin B1-induced hepatotoxicity through mitochondrial dysfunction, oxidative stress, and inflammation as central pathological mechanisms: A review of experimental evidence. Toxicology. 509. 153983–153983. 18 indexed citations

Ziqubu, Khanyisani, Sithandiwe E. Mazibuko-Mbeje, & Phiwayinkosi V. Dludla. (2024). Regulation of adipokine and batokine secretion by dietary flavonoids, as a prospective therapeutic approach for obesity and its metabolic complications. Biochimie. 230. 95–113. 3 indexed citations

Muvhulawa, Ndivhuwo, Sithandiwe E. Mazibuko-Mbeje, Duduzile Ndwandwe, et al.. (2023). Sarcopenia in a type 2 diabetic state: Reviewing literature on the pathological consequences of oxidative stress and inflammation beyond the neutralizing effect of intracellular antioxidants. Life Sciences. 332. 122125–122125. 3 indexed citations

Muvhulawa, Ndivhuwo, Phiwayinkosi V. Dludla, Sinenhlanhla X. H. Mthembu, et al.. (2023). Rutin attenuates tumor necrosis factor-α-induced inflammation and initiates fat browning in 3T3-L1 adipocytes: Potential therapeutic implications for anti-obesity therapy. South African Journal of Botany. 160. 697–704. 9 indexed citations

Dludla, Phiwayinkosi V., Ndivhuwo Muvhulawa, Albertus K. Basson, et al.. (2023). Global Trends in Risk Factors and Therapeutic Interventions for People with Diabetes and Cardiovascular Disease: Results from the WHO International Clinical Trials Registry Platform. SHILAP Revista de lepidopterología. 4(4). 560–573. 1 indexed citations

Dludla, Phiwayinkosi V., Khanyisani Ziqubu, Sihle E. Mabhida, et al.. (2023). Dietary Supplements Potentially Target Plasma Glutathione Levels to Improve Cardiometabolic Health in Patients with Diabetes Mellitus: A Systematic Review of Randomized Clinical Trials. Nutrients. 15(4). 944–944. 20 indexed citations

Ziqubu, Khanyisani, Phiwayinkosi V. Dludla, Sinenhlanhla X. H. Mthembu, et al.. (2023). An insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin. Frontiers in Endocrinology. 14. 1114767–1114767. 60 indexed citations

10.

Dludla, Phiwayinkosi V., Ilenia Cirilli, Fabio Marcheggiani, et al.. (2023). Potential Benefits of Coffee Consumption on Improving Biomarkers of Oxidative Stress and Inflammation in Healthy Individuals and Those at Increased Risk of Cardiovascular Disease. Molecules. 28(18). 6440–6440. 19 indexed citations

11.

Mthiyane, Doctor Mziwenkosi Nhlanhla, et al.. (2023). Dietary supplementation of low levels of unprocessed Mucuna pruriens utilis seed meal induces mild antinutritional entero-physio-metabolic perturbations without compromising performance and meat quality in finisher broilers. Tropical Animal Health and Production. 55(5). 336–336. 2 indexed citations

12.

Mthembu, Sinenhlanhla X. H., Patrick Orlando, Sonia Silvestri, et al.. (2022). Impact of dyslipidemia in the development of cardiovascular complications: Delineating the potential therapeutic role of coenzyme Q10. Biochimie. 204. 33–40. 10 indexed citations

13.

Jack, Babalwa, Khanyisani Ziqubu, Sithandiwe E. Mazibuko-Mbeje, et al.. (2022). Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties. Critical Reviews in Food Science and Nutrition. 64(1). 87–109. 37 indexed citations

14.

Pheiffer, Carmen, Sithandiwe E. Mazibuko-Mbeje, Sinenhlanhla X. H. Mthembu, et al.. (2021). Physical Exercise Potentially Targets Epicardial Adipose Tissue to Reduce Cardiovascular Disease Risk in Patients with Metabolic Diseases: Oxidative Stress and Inflammation Emerge as Major Therapeutic Targets. Antioxidants. 10(11). 1758–1758. 28 indexed citations

15.

Mazibuko-Mbeje, Sithandiwe E., Sinenhlanhla X. H. Mthembu, Phiwayinkosi V. Dludla, et al.. (2021). Antimycin A-induced mitochondrial dysfunction is consistent with impaired insulin signaling in cultured skeletal muscle cells. Toxicology in Vitro. 76. 105224–105224. 15 indexed citations

16.

Dludla, Phiwayinkosi V., Bongani B. Nkambule, Sithandiwe E. Mazibuko-Mbeje, et al.. (2020). Tea consumption and its effects on primary and secondary prevention of coronary artery disease: Qualitative synthesis of evidence from randomized controlled trials. Clinical Nutrition ESPEN. 41. 77–87. 20 indexed citations

17.

Dludla, Phiwayinkosi V., Tawanda M. Nyambuya, Rabia Johnson, et al.. (2020). Metformin and heart failure–related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials. Heart Failure Reviews. 26(6). 1437–1445. 33 indexed citations

18.

Dludla, Phiwayinkosi V., Sithandiwe E. Mazibuko-Mbeje, Tawanda M. Nyambuya, et al.. (2019). The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: A systematic review of pre-clinical studies. Pharmacological Research. 146. 104332–104332. 45 indexed citations

19.

Pfuhlmann, Katrin, Sonja C. Schriever, Peter Baumann, et al.. (2018). Celastrol-Induced Weight Loss Is Driven by Hypophagia and Independent From UCP1. Diabetes. 67(11). 2456–2465. 37 indexed citations

20.

Dludla, Phiwayinkosi V., Bongani B. Nkambule, Babalwa Jack, et al.. (2018). Inflammation and Oxidative Stress in an Obese State and the Protective Effects of Gallic Acid. Nutrients. 11(1). 23–23. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact